Zero ad trackers.We never sell your data.
Home/Rare Diseases/Pyruvate Dehydrogenase Complex Deficiency

Metabolic & Lysosomal

Pyruvate Dehydrogenase Complex Deficiency (PDCD) Clinical Trials

Also called PDCD, PDH Deficiency, PDHC Deficiency, Pyruvate Dehydrogenase Deficiency, PDHA1 Deficiency, Pyruvate dehydrogenase E1-alpha deficiency, Pyruvate dehydrogenase E1-beta deficiency, Pyruvate dehydrogenase E2 deficiency

Cells burn carbohydrates in steps. The pyruvate dehydrogenase complex handles a key one, turning pyruvate into acetyl-CoA, the fuel the mitochondria use to make energy.

View 4 active trialsMatch me to a trial

About Pyruvate Dehydrogenase Complex Deficiency

Cells burn carbohydrates in steps. The pyruvate dehydrogenase complex handles a key one, turning pyruvate into acetyl-CoA, the fuel the mitochondria use to make energy. When the complex fails, pyruvate is turned into lactic acid instead. Lactic acid builds up in the blood and brain, and the brain, which needs a constant energy supply, takes the most damage.

Most cases come from the PDHA1 gene on the X chromosome. Changes in PDHX, PDHB, DLD, DLAT or PDP1 cause the rest and are inherited in an autosomal recessive pattern, from both parents.

There is no FDA-approved drug for PDCD as of October 2026. The ketogenic diet, very high in fat and low in carbohydrates, is the standard treatment because it gives the brain fuel that bypasses the broken step. High-dose thiamine (vitamin B1) helps a minority of people, most often those with certain PDHA1 changes, so doctors usually try it. Care involves a metabolic specialist, a dietitian experienced with the ketogenic diet and a neurologist.

Common Symptoms of Pyruvate Dehydrogenase Complex Deficiency

Recognizing the signs of Pyruvate Dehydrogenase Complex Deficiency early can lead to faster diagnosis and better outcomes. Symptoms may vary in severity from person to person. If you or a loved one are experiencing any of the following, consider speaking with a specialist.

  • Lactic acid buildup, which can cause vomiting, fast breathing and an abnormal heartbeat
  • Weak, floppy muscles in infancy
  • Developmental delay
  • Seizures
  • Poor coordination or trouble walking
  • A small head size

Who Pyruvate Dehydrogenase Complex Deficiency Affects

Symptoms usually start soon after birth, though onset ranges from before birth to later childhood; in one review the median age at diagnosis was about 20 months. Most cases, 76% to 85%, come from the PDHA1 gene on the X chromosome. Boys with a PDHA1 change are affected, while girls range from no symptoms to as severe as boys, depending on which X chromosome is active in their cells, so boys and girls are diagnosed about equally often.

Find Your Next Step

Answer a few questions and we'll point you to the right tools and information for where you are right now.

Where are you in your Pyruvate Dehydrogenase Complex Deficiency journey?

Side Effect Explorer

Real-world side effect reports from the FDA Adverse Event Reporting System (FAERS). Includes both FDA-approved drugs and investigational therapies from active clinical trials. Click any drug to see what patients reported.

Loading side effect data...

Questions about side effects?
I can help you understand what these reports mean
Start withor ask

Genetic Testing

Genetic testing can confirm a diagnosis, guide treatment decisions, and identify family members who may be at risk.

Finding labs...

Trusted Pyruvate Dehydrogenase Complex Deficiency Resources

Reputable organizations and medical references for learning more about Pyruvate Dehydrogenase Complex Deficiency, including disease registries, foundation resources, and clinical guidelines.

FDA decision ahead
The FDA is due to decide on SL1009 (sodium dichloroacetate) (Saol Therapeutics) for Pyruvate dehydrogenase complex deficiency by December 30, 2026. Resubmission for a rare metabolic disorder with no approved treatment.
See all upcoming rare disease FDA decisions →

Active Clinical Trials for Pyruvate Dehydrogenase Complex Deficiency

Use this Pyruvate Dehydrogenase Complex Deficiency clinical trial finder to see the 4 studies recruiting patients in the United States and worldwide, with eligibility criteria in plain English. Of these, 2 test a treatment and 2 are observational studies or registries; each card says which. These studies play a critical role in advancing care for metabolic & lysosomal conditions and may offer access to treatments not yet widely available. Each trial below is sourced directly from ClinicalTrials.gov, with eligibility criteria translated into plain English to help patients and caregivers evaluate whether a study may be a fit.

New to trials? What Placebos and Randomization Actually Mean for You (In Plain English) · 4 min readWorried about cost? The Hidden Costs of Joining a Clinical Trial (And How to Get Help Paying for Them) · 4 min read
TrialsSite mapPipeline timeline

Note: Trial recruitment statuses on ClinicalTrials.gov may not immediately reflect recent FDA decisions, sponsor announcements, or enrollment changes. Always confirm a trial's current status directly with the study coordinator before making plans.

4 active trials worldwide
Filter:
Sort:
RECRUITINGObservational study, no treatment givenRecently updatedNCT03056794

Natural History and Advanced Genetic Study of Pyruvate Dehydrogenase Complex Deficiencies

Intervention: No intervention

Sponsor: University of Pittsburgh

Children and adults with pyruvate dehydrogenase complex deficiency (PDCD) are participating in a research study seeking to better understand the genetic causes, symptoms, usefulness of current treatments, and outcomes for these disorders. The research project involves completing ...

Ages not specified1 location
Started Sep 2015Updated 1 week agoEst. Sep 2030 (~3y 11m)
RECRUITINGTreatment trialPhase 2No updates in a whileNCT06887777

Efficacy and Safety of the Treatment of Pyruvate Dehydrogenase Deficiency Patients With Glycerol Phenylbutyrate (RAVICTI)

Intervention: Glycerol Phenylbutyrate 1100 MG/ML [Ravicti]

Sponsor: Assistance Publique - Hôpitaux de Paris

This is a phase II, multicenter, prospective, non-comparative clinical trial to assess the efficacy and safety of the treatment of pyruvate dehydrogenase deficiency (PDH) patients with glycerol phenylbutyrate (Ravicti®).

Ages 2 Years to 25 Years1 location
Started Oct 2025Updated 6 months agoEst. Apr 2026
RECRUITINGTreatment trialPhase 1No updates in a whileNCT06340685

Triheptanoin for Children With Primary-Specific Pyruvate Dehydrogenase Complex (PDC) Deficiency

Intervention: Triheptanoin

Sponsor: Jirair Krikor Bedoyan · Ultragenyx Pharmaceutical Inc

This is a medical research study to test a medication in patients with a disease called Pyruvate Dehydrogenase Complex (PDC) Deficiency. The medication is triheptanoin, which is currently FDA approved for the treatment of Long-Chain Fatty Acid Oxidation Disorders. Previous resear...

Ages 1 Year to 17 Years1 location
Started Jul 2024Updated 7 months agoEst. Dec 2028 (~2y 2m)
RECRUITINGPatient registry covering many conditionsHasn't posted an update in over a yearNCT01793168

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Sponsor: Sanford Health

CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily a...

Ages not specified2 locations
Started Jul 2010Updated 1 year agoEst. Dec 2100 (~74y 3m)
Get an email the day the FDA decides on SL1009

The decision is due December 30. You'll also hear when new Pyruvate Dehydrogenase Complex Deficiency trials open. Unsubscribe anytime.

You'll get new recruiting trials, changes to trials, FDA decisions and condition news for Pyruvate Dehydrogenase Complex Deficiency. Turn any of these off from the link in every email.

We never share your email. Unsubscribe anytime. Privacy policy
Find Pyruvate Dehydrogenase Complex Deficiency trials near you, ranked by distance →
Active trial locations2 cities in the US

Trial Pipeline

Jan 2021 to Oct 2031
2021
2023
2025
2027
2029
2031
now
Phase 1
Phase 2
Observational
RecruitingOpening soonDelayed startTodayHover a bar for trial details
Need help understanding these trials?
Answers with sources, in plain English
Start withor ask
Run a Pyruvate Dehydrogenase Complex Deficiency foundation or patient group?
You can put this live trial list on your own website. It updates itself, and it's free.
Get the embed code →

Data from ClinicalTrials.gov, U.S. National Library of Medicine.
Always talk to your doctor before considering a clinical trial.

Patient Communities

Connect with other Pyruvate Dehydrogenase Complex Deficiency patients, caregivers, and advocacy groups across Facebook groups, Reddit communities, and YouTube channels. These patient communities offer peer support, shared experiences, caregiver resources, and real-time discussion about Pyruvate Dehydrogenase Complex Deficiency treatments, clinical trial participation, and day-to-day disease management.

Find the right community
Answers with sources, in plain English
Start withor ask

Related Conditions

Conditions that share genes, symptoms or treatments with Pyruvate Dehydrogenase Complex Deficiency, followed by others in the metabolic & lysosomal category. Patients with Pyruvate Dehydrogenase Complex Deficiency may find relevant research, shared treatment pathways, or overlapping clinical trials among these related conditions.

Frequently Asked Questions About Pyruvate Dehydrogenase Complex Deficiency